News
-
-
PRESS RELEASE
EQS-Adhoc: Viromed Medical AG seeks extensive cooperation with a major global Group
Viromed Medical AG is seeking extensive cooperation with a major global Group in the pharmaceutical sector for the application of cold atmospheric pressure plasma in medicine. Expected initial revenues in the low double-digit million range by the second half of 2025 -
-
-
-
PRESS RELEASE
Viromed Medical AG is expanding its Management Board – Christian Strauch has been appointed as a new member of the Management Board
Viromed Medical AG appoints Christian Strauch as new Management Board member to enhance global marketing of cold plasma technology. Uwe Perbandt named Chairman -
-
PRESS RELEASE
EQS-Adhoc: Viromed Medical AG plans to acquire all shares in pharmedix GmbH by means of a capital increase against a contribution in kind, excluding subscription rights.
Viromed Medical AG plans to acquire pharmedix GmbH through a capital increase, expanding their healthcare portfolio. The acquisition aims for a revenue growth of 35% in 2025 -
-
PRESS RELEASE
EQS-Adhoc: Viromed Medical AG will not acquire ActivCell Group AG and is focusing on another strategic option with greater added value
Viromed Medical AG cancels acquisition of ActivCell Group AG, exploring more valuable strategic options. Focus shifts to advancing innovative medical device ViroCAP
